Subretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD

References

• GoverdhanSVLochheadJSubmacular hemorrhages after intravitreal bevacizumab for large occult choroidal neovascularisation in age-related macular degenerationBr J Ophthalmol20089221021217965104
   PubMed Web of Science ®Google Scholar
• OlivierSChowDRPackoKHMacCumberMWAwhCCSubretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degenerationOphthalmology200411112011208 Erratum in: Ophthalmology. 2004;111:1640.15177972
   PubMed Web of Science ®Google Scholar
• PolinerLSOlkRJBurgessDGordonMENatural history of retinal pigment epithelial detachments in age-related macular degenerationOphthalmology1986935435512425324
   PubMed Web of Science ®Google Scholar
• TheodossiadisGPPanagiotidisDGeorgalasIGMoschosMTheodossiadisPGRetinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degenerationGraefes Arch Clin Exp Ophthalmol2003241131812545287
   PubMed Web of Science ®Google Scholar
• ArnoldJJBlinderKJBresslerNMAcute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials TAP and VIP report no. 3Am J Ophthalmol200413768369615059708
   PubMed Web of Science ®Google Scholar
• GeliskenFInhoffenWKarim-ZodaKSubfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularizationGraefes Arch Clin Exp Ophthalmol200524319820315258778
   PubMed Web of Science ®Google Scholar
• DoDVBresslerNMBresslerSBLarge submacular hemorrhages after verteporfin therapyAm J Ophthalmol200413755856015013883
   PubMed Web of Science ®Google Scholar
• ChaudhryNALavaqueAJTomDELiggettPELarge submacular hemorrhage following PDT with verteporfin in patients with occult CNVM secondary to age-related macular degenerationOphthalmic Surg Lasers Imaging200738646817278540
   PubMedGoogle Scholar
• MatsushitaSNaitoTTakebayashiMSatoHShiotaHThe prognosis of cases with massive subretinal hemorrhage after photodynamic therapyJ Med Invest20085523123518797136
   PubMedGoogle Scholar
• KaragiannisDALadasIDParikakisEChanging from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?Clin Interv Aging2009445746120054410
   PubMed Web of Science ®Google Scholar
• HondaSHirabayashiHTsukaharaYNegiAAcute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurityGraefes Arch Clin Exp Ophthalmol20082461061106318320201
   PubMed Web of Science ®Google Scholar
• GibranSKSachdevAStapplerTNewsomeRWongDHiscottPHistological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)Br J Ophthalmol20079160260417166893
   PubMed Web of Science ®Google Scholar
• GhassemifarRLaiCMRakoczyPEVEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha− and mediates trans-epithelial resistance in cultured endothelial and epithelial cellsCell Tissue Res200532311712516163490
   PubMed Web of Science ®Google Scholar
• PengSAdelmanRARizzoloLJMinimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctionsInvest Ophthalmol Vis Sci2010513216322520042644
   PubMed Web of Science ®Google Scholar
• LohelaMBryMTammelaTAlitaloKVEGFs and receptors involved in angiogenesis versus lymphangiogenesisCurr Opin Cell Biol20092115416519230644
   PubMed Web of Science ®Google Scholar
• ZiemssenFHeiduschkaPPetersSGrisantiSSchraermeyerUChances and risks of anti-VEGF therapyKlin Monbl Augenheilkd200822577077818759208
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthUClinical safety of ranibizumab in age-related macular degenerationExpert Opin Drug Saf2010914916520001757
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMMichelsMKaiserPKHeierJSSyJPIanchulevTANCHOR Study GroupRanibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR studyOphthalmology2009116576519118696
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthUClinical safety of ranibizumab in age-related macular degenerationExpert Opin Drug Saf20109114916520001757
   PubMed Web of Science ®Google Scholar
• BoyerDSHeierJSBrownDMFrancomSFIanchulevTRubioRGA Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degenerationOphthalmology20091161731173919643495
   PubMed Web of Science ®Google Scholar
• ZiemssenFBartz-SchmidtKUGrisantiS(Side) effects of VEGF inhibitionOphthalmologe200610348449216763865
   PubMed Web of Science ®Google Scholar
• BaetemanCHoffartLGallandFRidingsBConrathJSubretinal hemorrhage after intravitreal injection of anti-VEGF for age-related macular degeneration: a retrospective studyJ Fr Ophtalmol20093230931319769866
   PubMed Web of Science ®Google Scholar
• TilanusMAVaandragerWCuypersMHVerbeekAMHoyngCBRelationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degenerationGraefes Arch Clin Exp Ophthalmol200023848248510943671
   PubMed Web of Science ®Google Scholar
• KiernanDFHariprasadSMRusuIMMehtaSVMielerWFJagerRDEpidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degenerationRetina2010301573157821060269
   PubMed Web of Science ®Google Scholar
• IguchiYItoYKikuchiMSeasonal variations of acute massive submacular hemorrhage associated with age-related macular degenerationBr J Ophthalmol2006901256125816837537
   PubMed Web of Science ®Google Scholar
• GrossniklausHEWilsonDJBresslerSBClinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST Report No. 16Am J Ophthalmol20061419310416386982
   PubMed Web of Science ®Google Scholar
• GlattHMachemerRExperimental subretinal hemorrhage in rabbitsAm J Ophthalmol1982947627737180915
   PubMed Web of Science ®Google Scholar
• BhisitkulRBWinnBJLeeOTNeuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhageInvest Ophthalmol Vis Sci20084994071407718421081
   PubMed Web of Science ®Google Scholar
• DaneshvarHKertesPJLeonardBCPeymanGAManagement of submacular hemorrhage with intravitreal sulfurhexafluoride: a pilot studyCan J Ophthalmol19993438538810649579
   PubMed Web of Science ®Google Scholar
• OhjiMSaitoYHayashiALewisJMTanoYPneumatic displacement of subretinal hemorrhage without tissue plasminogen activatorArch Ophthalmol1998116132613329790631
   PubMedGoogle Scholar
• PeymanGANelsonNCJrAlturkiWTissue plasminogen activating factor assisted removal of subretinal hemorrhageOphthalmic Surg1991225755821961614
   PubMedGoogle Scholar
• LimJIDrews-BotschCSternbergPCaponeAAabergTMSubmacular hemorrhage removalOphthalmology1995102139313999097779
   PubMed Web of Science ®Google Scholar
• ScheiderAGundischOKampikASurgical extraction of subfoveal choroidal new vessels and submacular hemorrhage in age-related macular degeneration: results of a prospective studyGraefes Arch Clin Exp Ophthalmol199923710159951635
   PubMed Web of Science ®Google Scholar
• LewisHIntraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainageAm J Ophthalmol19941185595687977569
   PubMed Web of Science ®Google Scholar
• YangPMKuoHKKaoMLChenYJTsaiHHPneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activatorChang Gung Med J2005281285285916515019
   PubMedGoogle Scholar
• ThompsonJTSjaardaRNVitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacementTrans Am Ophthalmol Soc200510398107 discussion 107.17057793
   PubMedGoogle Scholar
• KameiMTanoYTissue plasminogen activator-assisted vitrectomy: surgical drainage of submacular hemorrhageDev Ophthalmol200944828819494655
   PubMedGoogle Scholar
• HassanASJohnsonMWSchneidermanTEManagement of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacementOphthalmology19991061900190610519583
   PubMed Web of Science ®Google Scholar
• RatanasukonMKittantongAResults of intravitreal tissue plasminogen activator and expansile gas injection for submacular hemorrhage in ThaisEye (Lond)2005191328133215565185
   PubMed Web of Science ®Google Scholar
• ChenCYHooperCChiuDChamberlainMKariaNHeriotWJManagement of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gasRetina20072732132817460587
   PubMed Web of Science ®Google Scholar
• HaupertCLMcCuenBWJaffeGJPars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degenerationAm J Ophthalmol200113120821511228297
   PubMed Web of Science ®Google Scholar
• KameiMTanoYMaenoTIkunoYMitsudaHYuasaTSurgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquidAm J Ophthalmol19961212672758597269
   PubMed Web of Science ®Google Scholar
• StifterEMichelsSPragerFIntravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhageAm J Ophthalmol200714488689217916314
   PubMed Web of Science ®Google Scholar
• MeyerCHSchollHPEterNHelbHMHolzFGCombined treatment of acute subretinal hemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot studyActa Ophthalmol20088649049418221499
   PubMed Web of Science ®Google Scholar
• TreumerFKlattCRoiderJHillenkampJSubretinal co-application of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular hemorrhageBr J Ophthalmol201094485319946027
   PubMed Web of Science ®Google Scholar
• HillenkampJSurguchVFrammeCGabelVPSachsHGManagement of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activatorGraefes Arch Clin Exp Ophthalmol201024851119669780
   PubMed Web of Science ®Google Scholar
• MozaffariehMSacuSBeneschTWedrichASubretinal hemorrhages secondary to age-related macular degeneration: psychological and vision-related functional perspectivesOphthalmologica200822219920418497530
   PubMed Web of Science ®Google Scholar